SCMP Research
Webinar with Charles Li, CEO of HKEX
Webinar with Charles Li, CEO of HKEX

Webinar with Charles Li, CEO of hKEX

Webinar with Charles Li, CEO of HKEX
Webinar with Charles Li, CEO of HKEX

The Stock Exchange of Hong Kong (HKEX), which captured the global top spot in seven of the previous 11 years in initial public offerings (IPOs), overhauled its listing regulations in 2018, one of the most transformative changes in Hong Kong's financial markets in 30 years. The reform led to a flurry of IPOs by technology start-ups, biopharmaceutical laboratories and some of China's biggest tech champions, putting HKEX on track for another bumper year. In our upcoming webinar, SCMP's business editor Eugene Tang will interview HKEX's chief executive officer Charles Li Xiaojia on what's in store for the world's third-largest listed exchange.

Date And Time
Friday, 28th August, 2020
11:00 AM - 12:00 PM Hong Kong Time

USD $50

Looking for China Internet Report 2020 Pro Edition?

EXCLUSIVE

SPEAKERS

Capital raising for funding technology's growth

Charles Li Xiaojia

Eugene Tang

Chief Executive Officer
of HKEX

Business Editor at the South China Morning Post

aug 28, 2020

Capital raising for funding technology's growth 

Charles Li Xiaojia 

Chief Executive Officer
of HKEX

Eugene Tang

Business Editor at the South China Morning Post

AUG 28, 2020

WHAT'S INSIDE

Questions they will discuss

  • What's next for HKEX, after the 2018 listing reforms that opened the door for dual-class tech start-ups and pre-revenue biotech firms to list in Hong Kong?
  • What strategic position does HKEX occupy in China, with the Shenzhen Stock Exchange just across the border, and Shanghai's Star Market clamouring for deals?
  • What is the future for an exchange as a financial market place? As technology evolves, with data and AI coming to the fore, how will the operation of exchanges evolve over the next few years?

Contact Us

For business enquiries, customer feedback and questions, email us at research@scmp.com

ABOUT US
PRIVACY POLICY
TERMS & CONDITIONS

The content of this report is for information purposes only. Whilst every effort has been made to ensure accuracy, no warranty, expressed or implied is given on merchantability, accuracy, reliability and correctness of the content. We expressly exclude any and all liability, to the extent permissible under law, including but not limited to tort, negligence, all losses, damages, costs suffered or incurred by anyone in reliance on the report. You are specifically drawn to the attention that the report is not meant to be relied on and should not be construed as advice of any kind or the basis for making any commercial decision including but not limited to any investment decisions. The report may consist of opinion, data and information obtained from a wide range of sources, both public and private, market research, interviews and third party resources. We cite specific sources where data, research or insights are obtained from any third party. Any trademarks or service marks used in this report are the marks of their respective owners and may not have contributed to the content of the report and should not be read or construed as having made any endorsement to the content of the same. All rights in such marks are reserved by their respective owners. Purchase is nonrefundable and is subject to terms and conditions. Please visit here for details.